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Microcarriers are microspheres ranging from a few nanometers to some hundreds of
micrometers. One thousand nanometers equal one micrometer which is roughly half a millionth
of an inch. The advantages of using polymeric microcarriers include biodegradability, low
toxicity, and slow release. Microcarriers for drug delivery may be formed from two general
classes of polymers: the first, polyesters such as poly(lactide-co-glycolide) (PLGA); then the
second, polyolefins such as poly(meth)acrylates. PLGA microcarriers can successfully be
synthesized through a double emulsion process using sonication. These polyesters degrade in
vivo by hydrolysis of their ester backbone into nontoxic products, which are excreted by the
kidneys. The ratio of lactide to glycolide in the PLGA polymers, the molecular weight and the
terminal group of the PLGA polymer determine how fast drug release occurs. Carboxylterminated PLGA polymers offer faster drug release compared to ester-terminated PLGA. The
following provides two literature examples of how microcarriers for drug release will work. The
first example, published in 2015 [1], investigated the potential of PLGA based nanocarriers as a
novel strategy to enhance penetration of therapeutic molecules into white blood cells

(macrophages) as a model for HIV infection. Following infection, HIV establishes reservoirs in
macrophages that are inaccessible to optimal levels of antiviral drugs thus escaping the action of
anti-HIV drugs; and thus may contribute to the rebound observed after antiretroviral treatment is
stopped. To allow for more effective HIV treatment, stable polyester PLGA nanoparticles (NPs),
about 180 nm in size, were prepared. Their capacity to transport an active molecule into the
human macrophage cell line THP-1 using bovine serum albumin (BSA), a protein, as a proof-ofconcept compound was evaluated. It was shown that encapsulation of BSA into PLGA NPs
increased leukocyte infiltration in vivo, suggesting that enhanced delivery and protection of the
protein by the polymer nanocarrier occurred. The second example, published in 2005 [2],
describes the use of microparticles made from Eudragit P-4135F, a pH sensitive polyacrylate, for
the purpose of treating inflammatory bowel disease (IBD). Adding FK506, an
immunosuppressant, anti-inflammatory drug, to the microparticles provided efficient selective
colonic drug delivery to the inflamed gut tissue. The selective delivery of the FK506 was shown
to improve efficiency and tolerability in treating IBD. The important aspect of the study was that
the FK506 loaded microparticles were administered orally as well as subcutaneously, to infected
rats, resulting in a betterment in both cases. This shows a promise that oral administration may
work as well as subcutaneous application. A major explanation for this occurrence is that the
Eudragit P-4135F polymer protected the encapsulated FK506 from the acidity of the stomach
acids while releasing at a neutral pH. In vitro studies of FK506 release from Eudragit P-4135F
polymer microparticles confirmed that explanation. This proposal aims at exploring the
aforementioned types of microparticles in support of a potential interdisciplinary project between
the medical school, biology, and chemistry.

Christian worldview integration: The Christian Gospel is the message of “good news” for how
God has reconciled his image bearers to himself by offering forgiveness through the life, death,
and resurrection of Jesus Christ. Moreover, further pointing to the goodness of creation, in the
incarnation of Jesus, the eternal Son of God became flesh. Those who are in Christ are to be
working against the disorder that exists within the world. The benefits of polymeric nanoparticle
medicine could change the view of medicine in third world countries, where medicine is
expensive and scarce. The Bible tell us in Mark 16:15 to spread the gospel to the whole Earth. If
a nanoparticle that can be developed, by Christian’s, that can be administered to those who have
HIV one will be able to save their life, and the gospel can be shared with them. Also, there is
design in making the nanoparticles. There are many steps that are performed in making a
nanoparticle. Each step has a defined purpose in accomplishing the task of helping the
nanoparticle become biocompatible. An average human cell has a membrane that is both
hydrophilic and hydrophobic. This concept has to be integrated into our nanoparticle. We will
use certain polymers, like PLGA and Eudragit P-4135F, and proteins, like BSA, to create the
hydrophobic and hydrophilic components. God has given us a model, the cell, and has shown us
that we are able to replicate this idea into a new technique for medicine. It is incredible that
something that is classified as “nonliving” can form into an intelligent design to help God’s
people.
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